Multidisciplinary team model for patients with oral cancer and systemic diseases: an expert consensus

doi:10.7518/hxkq.2020.06.001

West China Journal of Stomatology ›› 2020, Vol. 38 ›› Issue (6): 603-615.doi: 10.7518/hxkq.2020.06.001

Multidisciplinary team model for patients with oral cancer and systemic diseases: an expert consensus

Zhang Dongsheng¹(), Zheng Jiawei², Zhang Chenping², Cai Zhigang³, Li Longjiang⁴, Liao Guiqing⁵, Shang Zhengjun⁶, Sun Moyi⁷, Han Zhengxue⁸, Shang Wei⁹, Meng Jian¹⁰, Gong Zhongcheng¹¹, Huang Shengyun¹

1. Dept. of Oral and Maxillofacial Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250012, China
2. Dept. of Oromaxillofacial Head and Neck Oncology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China
3. Dept. of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Peking University, Beijing 100081, China
4. State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
5. Dept. of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Sun Yat-sen University, Guangzhou 510120, China
6. Dept. of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Wuhan University, Wuhan 430070, China
7. Dept. of Oral and Maxillofacial Surgery, The Third Affiliated Hospital, Air Force Medical University, Xi’an 710032, China
8. Dept. of Head and Neck Oncology Surgery, Beijing Stomatological Hospital, Capital Medical University, Beijing 100050, China
9. Dept. of Oral and Maxillofacial Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266003, China
10. Dept. of Stomatology, Xuzhou Central Hospital, Xuzhou 221009, China
11. Dept. of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China

Received:2020-04-19 Revised:2020-06-10 Online:2020-12-01 Published:2020-12-07
Contact: Zhang Dongsheng E-mail:ds63zhang@sdu.edu.cn
Supported by:
The National Natural Science 入Foundation of China(81901022);The National Natural Science 入Foundation of China(81470755);The National Natural Science 入Foundation of China(81771087)

Abstract

Abstract:

Large general hospitals currently play an increasingly important role in the diagnosis and treatment for acute critical patients and difficult diseases because of the development of dual referral system and hierarchical diagnosis, as well as the formation of medical treatment alliance. Patients with oral cancers are often associated with systemic diseases, which increases the complexity of the condition. Thus, meeting the demand through the traditional single medical model is difficult. As such, a multidisciplinary team (MDT) model has been proposed and has achieved a good clinical effect. To standardize the application of this model, we organized an event in which relevant experts discussed and formulated a consensus to provide standardized suggestions on the MDT process and the diagnosis and treatment of common systemic diseases as reference for clinical practice.

Key words: oral cancer, multidisciplinary team, systemic disease, expert consensus

CLC Number:

R739.8

Zhang Dongsheng, Zheng Jiawei, Zhang Chenping, Cai Zhigang, Li Longjiang, Liao Guiqing, Shang Zhengjun, Sun Moyi, Han Zhengxue, Shang Wei, Meng Jian, Gong Zhongcheng, Huang Shengyun. Multidisciplinary team model for patients with oral cancer and systemic diseases: an expert consensus[J]. West China Journal of Stomatology, 2020, 38(6): 603-615.

Figures/Tables 2

References 61

[1]	Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424. URL pmid: 30207593
[2]	Feng RM, Zong YN, Cao SM, et al. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics[J]. Cancer Commun (Lond), 2019,39(1):22.
[3]	Lamb BW, Sevdalis N, Benn J, et al. Multidisciplinary cancer team meeting structure and treatment decisions: a prospective correlational study[J]. Ann Surg Oncol, 2013,20(3):715-722. doi: 10.1245/s10434-012-2691-x URL pmid: 23064794
[4]	Grass C, Umansky R. Problems in promoting the growth of multi-disciplinary diagnostic and counseling clinics for mentally retarded children in nonmetropolitan areas[J]. Am J Public Health, 1971,61(4):698-710. URL pmid: 5139748
[5]	Poulton BC, West MA. Effective multidisciplinary teamwork in primary health care[J]. J Adv Nurs, 1993,18(6):918-925. doi: 10.1046/j.1365-2648.1993.18060918.x URL pmid: 8320386
[6]	Catterall A. Guidelines for surgeons in the management of symptomatic breast disease in the United Kingdom[J]. Eur J Surg Oncol, 1996,22(2):202. doi: 10.1016/s0748-7983(96)91009-4 URL pmid: 8608845
[7]	Fleissig A, Jenkins V, Catt S, et al. Multidisciplinary teams in cancer care: are they effective in the UK[J]. Lancet Oncol, 2006,7(11):935-943. doi: 10.1016/S1470-2045(06)70940-8 URL pmid: 17081919
[8]	De Felice F, Tombolini V, de Vincentiis M, et al. Multidisciplinary team in head and neck cancer: a management model[J]. Med Oncol, 2018,36(1):2. URL pmid: 30426243
[9]	National Comprehensive Cancer Network(NCCN). Guidelines head and neck cancers[M]. 2nd ed. Philadelphia: National Comprehensive Cancer Network, 2018.
[10]	Wright JT Jr, Fine LJ, Lackland DT, et al. Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view[J]. Ann Intern Med, 2014,160(7):499-503. doi: 10.7326/M13-2981 URL pmid: 24424788
[11]	中国高血压防治指南修订委员会. 中国高血压防治指南2018年修订版[J]. 心脑血管病防治, 2019,19(1):1-44.
	Committee of Revision of Chinese Guidelines for Hypertension Prevention and Control. 2018 Chinese guidelines for the management of hypertension[J]. Prevent Treat Cardio Cerebral Vascular Dis, 2019,19(1):1-44.
[12]	Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension[J]. J Clin Hypertens (Greenwich), 2014,16(1):14-26. doi: 10.1111/jch.12237 URL
[13]	国家卫生计生委合理用药专家委员会, 中国医师协会高血压专业委员会. 高血压合理用药指南(第2版)[J]. 中国医学前沿杂志, 2017,9(7):28-126.
	National Health and Family Planning Commission Expert Committee on Rational Drug Use, Hypertension Professional Committee of Chinese Medical Doctors Association. Guidelines for rational use of hypertension (2nd edition)[J]. Chin J Front Med Sci, 2017,9(7):28-126.
[14]	国家卫生计生委合理用药专家委员会, 中国药师协会. 冠心病合理用药指南(第2版)[J]. 中国医学前沿杂志, 2018,10(6):1-130.
	National Health and Family Planning Commission Expert Committee on Rational Drug Use, Chinese Pharmacists Association. Guidelines for rational use of coronary heart disease (2nd edition)[J]. Chin J Front Med Sci, 2018,10(6):1-130.
[15]	Albaladejo P, Marret E, Piriou V, et al. Perioperative management of antiplatelet agents in patients with coronary stents: recommendations of a French Task Force[J]. Br J Anaesth, 2006,97(4):580-582. doi: 10.1093/bja/ael228 URL pmid: 16956897
[16]	Baron JF, Bertrand M, Barré E, et al. Combined epidural and general anesthesia versus general anesthesia for abdominal aortic surgery[J]. Anesthesiology, 1991,75(4):611-618. doi: 10.1097/00000542-199110000-00010 URL pmid: 1928770
[17]	中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中华糖尿病杂志, 2018,10(1):4-67.
	Chinese Diabetes Society. Guidelines for the prevention and treatment of type 2 diabetes in China (version 2017)[J]. Chin J Diabetes, 2018,10(1):4-67.
[18]	张彤彦, 许媛. 围手术期的血糖控制[J]. 临床药物治疗杂志, 2010,8(4):9-11
	Zhang TY, Xu Y. Perioperative blood glucose control[J]. Clin Med J, 2010,8(4):9-11.
[19]	Kehlet H. The surgical stress response: should it be prevented[J]. Can J Surg, 1991,34(6):565-567. URL pmid: 1747833
[20]	Agostini P, Cieslik H, Rathinam S, et al. Postoperative pulmonary complications following thoracic surgery: are there any modifiable risk factors[J]. Thorax, 2010,65(9):815-818. doi: 10.1136/thx.2009.123083 URL pmid: 20805178
[21]	王天佑, 李单青, 崔永, 等. 胸外科围手术期肺保护中国专家共识(2019版)[J]. 中国胸心血管外科临床杂志, 2019,26(9):835-842.
	Wang TY, Li DQ, Cui Y, et al. Consensus of Chinese experts on perioperative lung protection in thoracic surgery (version 2019)[J]. Chin J Clin Thorac Cardiov Surg, 2019,26(9):835-842.
[22]	车国卫, 吴齐飞, 邱源, 等. 多学科围手术期气道管理中国专家共识(2018版)[J]. 中国胸心血管外科临床杂志, 2018,25(7):545-549.
	Che GW, Wu QF, Qiu Y, et al. Multidisciplinary perioperative airway management expert consensus in China (version 2018)[J]. Chin J Clin Thorac Cardiov Surg, 2018,25(7):545-549.
[23]	Taylor MD, LaPar DJ, Isbell JM, et al. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer[J]. J Thorac Cardiovasc Surg, 2014,147(2):738-744. doi: 10.1016/j.jtcvs.2013.09.064 URL pmid: 24252944
[24]	中华医学会外科学分会, 中华医学会麻醉学分会. 加速康复外科中国专家共识及路径管理指南(2018版)[J]. 中国实用外科杂志, 2018,38(1):1-20.
	Chinese Medical Association Surgery Branch, Chinese Medical Association Anesthesiology Branch. Chinese expert consensus and path management guide for accelerated rehabilitation surgery (version 2018)[J]. Chin J Pract Surg, 2018,38(1):1-20.
[25]	Lai YT, Huang J, Yang M, et al. Seven-day intensive preoperative rehabilitation for elderly patients with lung cancer: a randomized controlled trial[J]. J Surg Res, 2017,209:30-36. doi: 10.1016/j.jss.2016.09.033 URL pmid: 28032568
[26]	欧阳葆怡, 吴新民. 肌肉松弛药合理应用的专家共识(2013)[J]. 临床麻醉学杂志, 2013,29(7):712-715.
	Ou-yang BY, Wu XM. Expert consensus on the rational use of muscle relaxants (2013)[J]. J Clin Anesthesiol, 2013,29(7):712-715.
[27]	Marx G, Schindler AW, Mosch C, et al. Intravascular volume therapy in adults: guidelines from the association of the scientific medical societies in Germany[J]. Eur J Anaesthesiol, 2016,33(7):488-521. doi: 10.1097/EJA.0000000000000447 URL pmid: 27043493
[28]	王成硕, 程雷, 刘争, 等. 耳鼻咽喉头颈外科围术期气道管理专家共识[J]. 中国耳鼻咽喉头颈外科, 2019,26(9):463-471
	Wang CS, Cheng L, Liu Z, et al. Consensus on perioperative airway management in otolaryngology head and neck surgery[J]. Chin Arch Otolaryngol Head Neck Surg, 2019,26(9):463-471.
[29]	中华医学会胸心血管外科学分会胸腔镜外科学组, 中国医师协会胸外科医师分会微创外科专家委员会. 中国胸外科围手术期疼痛管理专家共识(2018版)[J]. 中国胸心血管外科临床杂志, 2018,25(11):921-928.
	Thoracoscopic Surgery Group, Thoracic and Cardiovascular Surgery Branch, Chinese Medical Association, Minimally Invasive Surgery Expert Committee, Thoracic surgeons Branch, Chinese Medical Doctor Association. Chinese expert consensus on perioperative pain management in thoracic surgery (version 2018)[J]. Chin J Clin Thorac Cardiov Surg, 2018,25(11):921-928.
[30]	Hinther A, Nakoneshny SC, Chandarana SP, et al. Efficacy of postoperative pain management in head and neck cancer patients[J]. J Otolaryngol Head Neck Surg, 2018,47(1):29. doi: 10.1186/s40463-018-0274-y URL pmid: 29720267
[31]	王学锋, 蔡晓红. 出血性疾病治疗应用血液制剂的专家共识[J]. 中国输血杂志, 2017,30(7):661-663.
	Wang XF, Cai XH. Expert consensus on the application of blood preparations in the treatment of hemorrhagic diseases[J]. Chin J Blood Transfusion, 2017,30(7):661-663.
[32]	Goodnough LT, Shander A, Riou B. Patient blood management[J]. Anesthesiology, 2012,116(6):1367-1376. doi: 10.1097/ALN.0b013e318254d1a3 URL pmid: 22487863
[33]	Linkins LA, Dans AL, Moores LK, et al. Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines[J]. Chest, 2012,141(2 Suppl):e495S-e530S. doi: 10.1378/chest.11-2303 URL pmid: 22315270
[34]	中国心胸血管麻醉学会血液管理分会. 心血管手术患者血液管理专家共识[J]. 中国输血杂志, 2018,31(4):321-325.
	Chinese Society for Patient Blood Management. Chinese experts consensus statement on patient blood management in patients undergoing cardiovascular surgery[J]. Chin J Blood Transf, 2018,31(4):321-325.
[35]	周宗科, 翁习生, 孙天胜, 等. 中国骨科手术加速康复——围术期血液管理专家共识[J]. 中华骨与关节外科杂志, 2017,10(1):1-7.
	Zhou ZK, Weng XS, Sun TS, et al. Expert consensus in enhanced recovery after orthopedic surgery in China: perioperative blood management[J]. Chin J Bone Joint Surg, 2017,10(1):1-7.
[36]	Tiede A, Giangrande P, Teitel J, et al. Clinical evaluation of bleeds and response to haemostatic treatment in patients with acquired haemophilia: a global expert consensus statement[J]. Haemophilia, 2019,25(6):969-978. doi: 10.1111/hae.13844 URL pmid: 31517435
[37]	John PG, John F, John NL, et al. Wintrobe’s clinical hematology[M]. 11th ed. Philadelphia: Lippincott Williams & Wilkins, 2004: 1620-1658.
[38]	中华医学会血液学分会血栓与止血学组, 中国血友病协作组. 血友病诊断与治疗中国专家共识(2017年版)[J]. 中华血液学杂志, 2017,38(5):364-370.
	Thrombosis and Hemostasis Group, Hematology Societ. Consensus of Chinese expert on the diagnosis and treatment of hemophilia (version 2017)[J]. Chine J Hematol, 2017,38(5):364-370.
[39]	Lison S, Spannagl M. Perioperative management of patients with hemophilia[J]. Anaesjournalt, 2014,63(1):6-15.
[40]	上海慢性肾脏病早发现及规范化诊治与示范项目专家组. 慢性肾脏病筛查诊断及防治指南[J]. 中国实用内科杂志, 2017,37(1):28-34.
	Expert Group on Early Detection Diagnosis and Treatment. Guideline for screening, diagnosis, prevention and treatment of chronic kidney disease[J]. Chin J Pract Int Med, 2017,37(1):28-34.
[41]	Hebert LA, Wilmer WA, Falkenhain ME, et al. Renoprotection: one or many therapies[J]. Kidney Int, 2001,59(4):1211-1226. doi: 10.1046/j.1523-1755.2001.0590041211.x URL pmid: 11260381
[42]	中国医师协会内分泌代谢科医师分会. 2型糖尿病合并慢性肾脏病口服降糖药用药原则中国专家共识(2015年更新版)[J]. 中华内分泌代谢杂志, 2016,32(6):455-460.
	Endocrinologist Branch of Chinese Medical Doctor Association. Principles of oral hypoglycemic drug use for type 2 diabetes mellitus with chronic kidney disease (updated version 2015)[J]. Chin J Endocrinol Metab, 2016,32(6):455-460.
[43]	Sinisa S, Vlado J, Petar K, et al. Perioperative management of patients with chronic renal failure[J]. Actaclin Croat, 2004,43:397-415.
[44]	Palevsky PM. Perioperative management of patients with chronic kidney disease or ESRD[J]. Best Pract Res Clin Anaesthesiol, 2004,18(1):129-144. doi: 10.1016/j.bpa.2003.08.003 URL pmid: 14760878
[45]	Kanda H, Hirasaki Y, Iida T, et al. Perioperative management of patients with end-stage renal disease[J]. J Cardiothorac Vasc Anesth, 2017,31(6):2251-2267. URL pmid: 28803771
[46]	复旦大学附属中山医院围手术期处理多学科团队. 普外科病人围手术期血栓预防——中山共识(2)[J]. 中国实用外科杂志, 2013,33(11):946-948.
	Multidisciplinary Team of Perioperative Management in Zhongshan Hospital Affiliated to Fudan University. Perioperative thrombosis prevention in general surgery patients—Zhongshan consensus (2)[J]. Chin J Pract Surg, 2013,33(11):946-948.
[47]	中国血栓性疾病防治指南专家委员会. 中国血栓性疾病防治指南[J]. 中华医学杂志, 2018,98(36):2861-2888.
	Expert Committee of Chinese Guidelines for the Prevention and Treatment of Thrombotic Diseases. Chinese guidelines for the prevention and treatment of thrombotic diseases[J]. Natl Med J China, 2018,98(36):2861-2888.
[48]	中华医学会外科学分会. 中国普通外科围手术期血栓预防与管理指南[J]. 中国实用外科杂志, 2016,36(5):469-474.
	Chinese Medical Association Surgery Branch. Guidelines for perioperative thrombosis prevention and management in Chinese general surgery[J]. Chin J Pract Surg, 2016,36(5):469-474.
[49]	Caprini JA. Risk assessment as a guide for the prevention of the many faces of venous thromboembolism[J]. Am J Surg, 2010,199(1 Suppl):S3-S10. doi: 10.1016/j.amjsurg.2009.10.006 URL pmid: 20103082
[50]	Gould MK, Garcia DA, Wren SM. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines[J]. Chest, 2012,141(2):227-277.
[51]	Bates SM, Jaeschke R, Stevens SM, et al. Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines[J]. Chest, 2012,141(2 Suppl):e351S-e418S. doi: 10.1378/chest.11-2299 URL pmid: 22315267
[52]	唐丽丽, 王建. 心理社会肿瘤学[M]. 北京: 北京大学医学出版社, 2012: 148-153.
	Tang LL, Wang J. Psycho-oncology[M]. Beijing: Peking University Medical Press, 2012: 148-153.
[53]	Loscalzo MJ, Von Gunten CF. Interdisciplinary teamwork in palliative care: compassionate expertise for serious complex illness//Chochinov HM, Breitbar TW. Handbook of psychiatry in palliative medicine[M]. New York: Oxford University Press, 2009: 172-185.
[54]	American Psychiatric Association. Desk reference to the diagnostic criteria from DSM-5[M]. Arlington: American Psychiatric Association, 2013: 157-166.
[55]	Elsayem AF, Bruera E, Valentine AD, et al. Delirium frequency among advanced cancer patients presenting to an emergency department: a prospective, randomized, observational study[J]. Cancer, 2016,122(18):2918-2924. doi: 10.1002/cncr.30133 URL pmid: 27455035
[56]	Bush SH, Lawlor PG, Ryan K, et al. Delirium in adult cancer patients: ESMO clinical practice guidelines[J]. Ann Oncol, 2018, 29(Suppl 4): iv143-iv165. doi: 10.1093/annonc/mdy147 URL
[57]	Aldecoa C, Bettelli G, Bilotta F, et al. European Society of Anaesthesiology evidence-based and consensus-based guideline on postoperative delirium[J]. Eur J Anaesthesiol, 2017,34(4):192-214. URL pmid: 28187050
[58]	Makiguchi T, Yokoo S, Kurihara J. Risk factors for postoperative delirium in patients undergoing free flap reconstruction for oral cancer[J]. Int J Oral Maxillofac Surg, 2018,47(8):998-1002. doi: 10.1016/j.ijom.2018.03.011 URL pmid: 29650354
[59]	Edelstein A, Alici Y. Diagnosing and managing delirium in cancer patients[J]. Oncology, 2017,31(9):686-692. URL pmid: 29071696
[60]	Hirsch J, DePalma G, Tsai TT, et al. Impact of intraoperative hypotension and blood pressure fluctuations on early postoperative delirium after non-cardiac surgery[J]. Br J Anaesth, 2015,115(3):418-426. doi: 10.1093/bja/aeu458 URL pmid: 25616677
[61]	国家卫生计生委合理用药专家委员会, 中国药师协会. 冠心病合理用药指南(第2版)[J]. 中国医学前沿杂志(电子版), 2018,10(6):1-130.
	Expert Committee of Rational Drug Use, National Health and Family Planning Commission, Chinese Pharmacists Association. Guidelines for rational drug use for coronary heart disease (2nd edition)[J]. Chin J Front Med Sci (Electr Vers), 2018,10(6):1-130.

Multidisciplinary team model for patients with oral cancer and systemic diseases: an expert consensus

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 61

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Chen Yunmei, Liu Yan, Huang Qiuyu, Luo Jiang, Wu Hongmei, Wang Yehua, Wu Ling, Li Xiu’e, Bi Xiaoqin. Facial nerve function training in patients with peripheral facial paralysis: an expert consensus [J]. West China Journal of Stomatology, 2023, 41(6): 613-621.
[2]	Lin Li, Li Zhaorong, Jin Yining, Yin Shou-cheng.. Treatment strategies for periodontitis patients with systemic disease [J]. West China Journal of Stomatology, 2023, 41(5): 502-511.
[3]	Liu Lei, Xiang Zhongzheng, Li Yi, Guo Wei, Yang Kai, Wang Jun, Sun Zhijun, Ren Guoxin, Zhang Jianguo, Sun Moyi, Ran Wei, Huang Guilin, Tang Zhangui, Li Longjiang. The immune checkpoint inhibitors treatment of head and neck squamous cell carcinoma: an expert consensus [J]. West China Journal of Stomatology, 2022, 40(6): 619-628.
[4]	Zhang Qiong, Wang Jun, Xia Bin, Zhao Wei, Chen Xu, Jiang Beizhan, Huang Yang, Wu Li’an, Yuan Guohua, Zou Jing. Expert consensus on clinical management for early childhood caries [J]. West China Journal of Stomatology, 2022, 40(5): 495-503.
[5]	Guo Weihua, Wang Jun, Chen Xu, Wang Xiaojing, Zhao Wei, Song Guangtai, Wu Li’an, Jiang Beizhan, Zhang Qiong, Wang Jun, Li Yu, Zhao Ning, Tan Jiali, Li Huang, Shu Rui, Zhou Chenchen, Fu Lei, Chen Xuepeng, Zou Jing. Experts’ consensus on space management of mixed dentition [J]. West China Journal of Stomatology, 2022, 40(3): 264-270.
[6]	Lu Qian, Guo Liumei, Bi Xiaoqin. Systematic review of risk factors of postoperative dysphagia in patients with oral cancer [J]. West China Journal of Stomatology, 2022, 40(3): 328-334.
[7]	Li Ruohan, Huang Yingzhao, Liao Nailin, Wu Chenzhou, Li Yi.. Oral cancer cells affect pancreatic β-cell function through transmissible endoplasmic reticulum stress [J]. West China Journal of Stomatology, 2022, 40(1): 22-31.
[8]	Jia Mei’e, Li Zhiyong, Xu Kai, Wang Yiheng, Yu Fei, He Xiangyi. Biological effects of exosome derived from Cal27 on normal human gingival fibroblasts [J]. West China Journal of Stomatology, 2021, 39(3): 313-319.
[9]	Liu Wei, Li Chunjie, Li Longjiang. Advances in molecular mechanisms of bone invasion by oral cancer [J]. West China Journal of Stomatology, 2021, 39(2): 221-226.
[10]	Yuan Quan. Oral implant treatment for elderly patients [J]. West China Journal of Stomatology, 2020, 38(6): 616-621.
[11]	Liao Min, Cheng Lei, Zhou Xuedong, Ren Biao. Research progress of Candida albicans on malignant transformation of oral mucosal diseases [J]. West China Journal of Stomatology, 2020, 38(4): 431-437.
[12]	Cheng Junxin, Bai Hetian, Chang Zhinan, Li Jing, Chen Qianming. Development of precancerous lesions of oral mucous membrane diseases and oral cancer animal models [J]. West China Journal of Stomatology, 2020, 38(2): 198-204.
[13]	Junfang Zhao,Zhian Zha,Weihong Xie,Haibin Wang,Xinming Li,Qiang Sun,Minglei Sun. Effect of long chain non-coding RNA H19 on the migration and invasion of oral cancer cells and its molecular mechanism [J]. West China Journal of Stomatology, 2019, 37(4): 378-383.
[14]	Shuaihua Qin, Xinming Li, Wenlu Li. Systematic retrospective study of oral cancer-related quality of life scale [J]. West China Journal of Stomatology, 2018, 36(4): 410-420.
[15]	Shuaihua Qin, Xinming Li, Wenlu Li. Influencing factors on the quality of life and medical coping style of patients with oral cancer [J]. West China Journal of Stomatology, 2018, 36(3): 271-276.